These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3473679

  • 1. Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cells.
    Muus P, Haanen C, Raijmakers R, de Witte T, Salden M, Wessels J.
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):238-44. PubMed ID: 3473679
    [Abstract] [Full Text] [Related]

  • 2. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C.
    Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
    [Abstract] [Full Text] [Related]

  • 3. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J.
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [Abstract] [Full Text] [Related]

  • 4. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 5. Synergistic cytotoxicity of cytosine arabinoside and mitoxantrone for K562 and CFU-GM.
    Krehmeier C, Zühlsdorf M, Büchner T, Hiddemann W.
    Haematol Blood Transfus; 1990 Jan; 33():129-32. PubMed ID: 2323625
    [Abstract] [Full Text] [Related]

  • 6. Different sensitivity of normal and leukaemic progenitor cells to Ara-C and IL-3 combined treatment.
    Lista P, Brizzi MF, Rossi M, Resegotti L, Clark SC, Pegoraro L.
    Br J Haematol; 1990 Sep; 76(1):21-6. PubMed ID: 2223644
    [Abstract] [Full Text] [Related]

  • 7. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P.
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [Abstract] [Full Text] [Related]

  • 8. In vitro sensitivity of CFU-L to cytosine arabinoside (Ara-C).
    Marie JP, Zittoun R.
    Med Pediatr Oncol; 1982 Aug; 10 Suppl 1():263-7. PubMed ID: 6962323
    [Abstract] [Full Text] [Related]

  • 9. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
    Colly LP, Peters WG, Willemze R.
    Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T.
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [Abstract] [Full Text] [Related]

  • 11. Anti-CD33 monoclonal antibody and etoposide/cytosine arabinoside combinations for the ex vivo purification of bone marrow in acute nonlymphocytic leukemia.
    Stiff PJ, Schulz WC, Bishop M, Marks L.
    Blood; 1991 Jan 15; 77(2):355-62. PubMed ID: 1985700
    [Abstract] [Full Text] [Related]

  • 12. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H, Vita M, Sallam H, Tehranchi R, Nilsson C, Sidén A, Hassan Z.
    Cancer Chemother Pharmacol; 2007 Nov 15; 60(6):841-9. PubMed ID: 17318617
    [Abstract] [Full Text] [Related]

  • 13. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
    Bhalla K, MacLaughlin W, Cole J, Arlin Z, Baker M, Graham G, Grant S.
    Blood; 1987 Aug 15; 70(2):568-71. PubMed ID: 3607288
    [Abstract] [Full Text] [Related]

  • 14. Differential protection of normal and malignant human myeloid progenitors (CFU-GM) from Ara-C toxicity using cycloheximide.
    Slapak CA, Fine RL, Richman CM.
    Blood; 1985 Oct 15; 66(4):830-4. PubMed ID: 3862435
    [Abstract] [Full Text] [Related]

  • 15. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A, De Felice L, Mascolo MG, Valentini T, Petrucci MT, Petti MC.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():88-92. PubMed ID: 7691332
    [Abstract] [Full Text] [Related]

  • 16. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR.
    Leukemia; 1992 May 15; 6(5):432-9. PubMed ID: 1593908
    [Abstract] [Full Text] [Related]

  • 17. Effect of the interval between exposures to cytarabine on its cytotoxic action on HL-60 myeloid leukemic cells.
    Leclerc JM, Momparler RL.
    Cancer Treat Rep; 1984 Sep 15; 68(9):1143-8. PubMed ID: 6592037
    [Abstract] [Full Text] [Related]

  • 18. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD.
    Leukemia; 1991 May 15; 5(5):386-91. PubMed ID: 1709711
    [Abstract] [Full Text] [Related]

  • 19. Interaction of deoxycytidine and deoxycytidine analogs in normal and leukemic human myeloid progenitor cells.
    Grant S, Bhalla K, Gleyzer M.
    Leuk Res; 1986 May 15; 10(9):1139-46. PubMed ID: 2429121
    [Abstract] [Full Text] [Related]

  • 20. Enhanced tumor load reduction after chemotherapy induced recruitment and synchronization in a slowly growing rat leukemia model (BNML) for human acute myelocytic leukemia.
    Colly LP, van Bekkum DW, Hagenbeek A.
    Leuk Res; 1984 May 15; 8(6):953-63. PubMed ID: 6595483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.